Table 1

Biographical summary of characteristics of subjects given bilateral subthalamic nucleus deep brain stimulation

SubjectSexAge (years)Formal education (years)Disease duration (years)Age at onset (years)Disease severityPrimary symptomSide affectedDrug treatment (preop daily dose (mg))Drug treatment (postop daily dose (mg))
PrePost
Disease severity is given by the Hoehn and Yahr scale score.17
F, female; L, left; M, male; postop, postoperative; preop, preoperative; R, right; BL, bilateral.
1M621416464.02.5BradykinesiaBL (L>R)Sinemet (1000)Sinemet (1000)
Comtan (600)
2F621013493.03.0TremorBL (R>L)Madopar (750)Madopar (500)
Symmetrel (200)
3M6884645.04.0BradykinesiaBLSymmetrel (300)Sinemet (825)
Sinemet (1100)Madopar (125)
Madopar (250)
4M681514542.02.0TremorBL (R>L)Madopar (500)Cabaser (1 mg)
Tambacor (100)
Betaloc (50)
5M561010462.02.0TremorBL (R>L)Madopar (750)Madopar (750)